Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$831K Buy
3,756
+1,157
+45% +$283K 0.01% 964
2025
Q4
$659K Sell
2,599
-283
-10% -$71.1K 0.01% 1004
2025
Q3
$713K Buy
2,882
+270
+10% +$64.6K 0.01% 1000
2025
Q2
$627K Sell
2,612
-738
-22% -$172K 0.01% 929
2025
Q1
$759K Buy
3,350
+1,048
+46% +$231K 0.01% 834
2024
Q4
$473K Buy
2,302
+326
+16% +$71.5K 0.01% 984
2024
Q3
$479K Sell
1,976
-970
-33% -$227K 0.01% 942
2024
Q2
$647K Buy
2,946
+1,459
+98% +$317K 0.02% 767
2024
Q1
$334K Sell
1,487
-645
-30% -$145K 0.01% 976
2023
Q4
$469K Buy
2,132
+94
+5% +$19.9K 0.01% 805
2023
Q3
$447K Buy
+2,038
New +$461K 0.01% 742

Other funds holding STE

Vident Advisory's STE Position: Q1 2026 in Review

Vident Advisory increased its Steris (STE) stake by 45% in Q1 2026, buying an estimated $283K and bringing the position to 3,756 shares worth $831K. The position accounts for 0.01% of the portfolio, ranked #964.

Vident Advisory first reported a position in STE in Q3 2023 and has held it in 11 quarters since. 838 funds tracked by Wall St. Rank hold STE as of Q1 2026.

  • Vident Advisory held 3,756 shares of Steris worth $831K as of Q1 2026.
  • Vident Advisory bought 1,157 Steris shares in Q1 2026, an estimated $283K.
  • Steris made up 0.01% of Vident Advisory's portfolio in Q1 2026, its #964 holding.
  • Vident Advisory first reported a position in Steris in Q3 2023 and has held it in 11 quarters since.
  • 838 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.